LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Torin1 | 0.12 | uM | LJP6 | 3 | O17 | 72 | hr | 1097 | 1324 | 3769 | 0.3512 | 0.0849 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 1 | I23 | 72 | hr | 1097 | 930 | 3769 | 0.2467 | -0.0626 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 2 | I23 | 72 | hr | 1097 | 920 | 3769 | 0.2441 | -0.0663 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 3 | I23 | 72 | hr | 1097 | 930 | 3769 | 0.2467 | -0.0626 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1097 | 1303 | 3769 | 0.3457 | 0.0770 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 1097 | 1374 | 3769 | 0.3645 | 0.1036 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 1097 | 1492 | 3769 | 0.3958 | 0.1477 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 1097 | 2963 | 3769 | 0.7860 | 0.6982 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 1097 | 2973 | 3769 | 0.7887 | 0.7019 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 1097 | 3187 | 3769 | 0.8455 | 0.7820 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 1 | M05 | 72 | hr | 1097 | 3687 | 3769 | 0.9781 | 0.9691 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 2 | M05 | 72 | hr | 1097 | 3867 | 3769 | 1.0259 | 1.0365 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 3 | M05 | 72 | hr | 1097 | 3717 | 3769 | 0.9861 | 0.9803 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 1097 | 3713 | 3769 | 0.9850 | 0.9788 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 1097 | 3651 | 3769 | 0.9686 | 0.9556 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 1097 | 3665 | 3769 | 0.9723 | 0.9609 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 1097 | 4198 | 3769 | 1.1137 | 1.1603 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 1097 | 4359 | 3769 | 1.1564 | 1.2206 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 1097 | 4152 | 3769 | 1.1015 | 1.1431 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 1097 | 3742 | 3769 | 0.9927 | 0.9897 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 1097 | 3628 | 3769 | 0.9625 | 0.9470 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 1097 | 3271 | 3769 | 0.8678 | 0.8134 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 1 | L11 | 72 | hr | 1097 | 1400 | 3769 | 0.3714 | 0.1133 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 2 | L11 | 72 | hr | 1097 | 1434 | 3769 | 0.3804 | 0.1260 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 3 | L11 | 72 | hr | 1097 | 1363 | 3769 | 0.3616 | 0.0994 |